XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Equity - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance at Dec. 31, 2022 $ 30,085 $ 9,762 $ 220 $ (13,772) $ 17,181 $ 16,499 $ 195  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 3,498         3,498    
Other comprehensive income (loss), net of tax 98           98  
Dividends on common stock (485)         (485)    
Dividends on preferred stock (567)         (567)    
Preferred stock redemption - face value (1,511) (1,511)            
Preferred stock redemption - premium (151)         (151)    
Preferred stock redemption value in excess of carrying value 0 36       (36)    
Shareholder warrants exercised 57       57      
Options exercised 13       13      
Issuance of common stock and other, net of cancellations 76   1   75      
Purchases of treasury stock (1,801)     (1,801)        
Ending balance at Sep. 30, 2023 29,312 8,287 221 (15,573) 17,326 18,758 293  
Beginning balance at Jun. 30, 2023 29,111 8,621 221 (14,958) 17,218 17,762 247  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,375         1,375    
Other comprehensive income (loss), net of tax 46           46  
Dividends on common stock (160)         (160)    
Dividends on preferred stock (177)         (177)    
Preferred stock redemption - face value (342) (342)            
Preferred stock redemption - premium (34)         (34)    
Preferred stock redemption value in excess of carrying value 0 8       (8)    
Shareholder warrants exercised 54       54      
Issuance of common stock and other, net of cancellations 54       54      
Purchases of treasury stock (615)     (615)        
Ending balance at Sep. 30, 2023 29,312 8,287 221 (15,573) 17,326 18,758 293  
Beginning balance at Dec. 31, 2023 30,250              
Beginning balance, including NCI at Dec. 31, 2023 30,349 8,287 222 (15,582) 17,422 19,626 275 $ 99
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 3,198         3,183   15
Other comprehensive income (loss), net of tax (26)           (26)  
Dividends on common stock (606)         (606)    
Dividends on preferred stock (509)         (509)    
Shareholder warrants exercised 554   4   550      
Issuance of common stock and other, net of cancellations 82   1   81      
Purchases of treasury stock (9)     (9)        
Common Stock issued for CrownRock acquisition 1,755   6   1,749      
Noncontrolling interest contributions, net 146             146
Ending balance, including NCI at Sep. 30, 2024 34,934 8,287 233 (15,591) 19,802 21,694 249 260
Ending balance at Sep. 30, 2024 34,674              
Beginning balance, including NCI at Jun. 30, 2024 32,259 8,287 227 (15,591) 17,928 20,938 264 206
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,140         1,133   7
Other comprehensive income (loss), net of tax (15)           (15)  
Dividends on common stock (208)         (208)    
Dividends on preferred stock (169)         (169)    
Shareholder warrants exercised 67       67      
Issuance of common stock and other, net of cancellations 58       58      
Common Stock issued for CrownRock acquisition 1,755   6   1,749      
Noncontrolling interest contributions, net 47             47
Ending balance, including NCI at Sep. 30, 2024 34,934 $ 8,287 $ 233 $ (15,591) $ 19,802 $ 21,694 $ 249 $ 260
Ending balance at Sep. 30, 2024 $ 34,674